1 / 3

Fexofenadine

Boc Sciences offers 83799-24-0 Fexofenadine in bulk, please inquire us to get a quote for 83799-24-0 Fexofenadine.t<br>https://www.bocsci.com/fexofenadine-cas-83799-24-0-item-354757.html<br>

bocsci2018
Download Presentation

Fexofenadine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fexofenadine - CAS 83799-24-0 Fexofenadine is Histamine H1 receptor antagonist. It can be used for the treatment of allergy symptoms, such as hay fever, nasal congestion, and urticaria. Please be kindly noted that our product can only be used for research to orgnizations or companies and we don't cooperate with personal buyers. Category Inhibitor Targets Histamine Receptor SARS-CoV-2 Molecular Formula C32H39NO4 Molecular Weight 501.66 Chemical Information Category Inhibitor Molecular Formula C32H39NO4 Molecular Weight 501.66 Specification Properties Reference Reading   

  2. Purity ≥98% Related CAS 153439-40-8 (hydrochloride) Appearance White Solid Synonyms Carboxyterfenadine; Terfenadine carboxylate; 4-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)-1-pip eridinyl]butyl]-α,α-dimethyl-benzene-acetic Acid; 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl] -1-hydroxybutyl]-α,α- dimethylphenylacetic Acid; MDL 16455; MDL16455; MDL-16455; Terfenadi ne Acid Metabolite Solubility Soluble in methanol. Storage Store at -20ºC Clinical Trial Information NCT Number Title Condition Or Disease Phase Start Date Sponsor Status NCT00044811Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma Asthma Phase 3 March 2002 Sanofi Completed NCT00044824Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma Asthma Phase 3 February 2002 Sanofi Completed NCT00261079Fexofenadine in Pruritic Skin Disease Pruritus Phase 4 April 2005Handok Completed Pharmaceuticals Co., Ltd. NCT00420082A Randomized, Double-Blind, 4- way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Seasonal Allergic Rhinitis Phase 2 October 2006 Faes Farma, S.A. Completed

  3. Chamber NCT00562120A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge Allergic Rhinitis Phase 2 December 2007 Pfizer Completed Publication citing BOC Sciences Products Bio Calculators Solution Dilution Calculator  Molecular Weight Calculator  Molarity Calculator Stock concentration: *  molar (M) Desired final volume: * liters (L) Desired concentration: * molar (M) L * Our calculator is based on the following equation: Concentration (start) x Volume (start) = Concentration (final) x Volume (final) It is commonly abbreviated as: C1V1 = C2V2 https://www.bocsci.com/fexofenadine-cas-83799-24-0-item-354757.html

More Related